Strength
25 mg/1
Manufacturer
AvPAKNDC
50268021715
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DANTROLENE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA076856On Market Since
3/9/2021
Pharmacological Classes
Price Statistics
The NADAC for DANTROLENE SODIUM 25 MG CAP has been published 259 times since Jul 14, 2021, and over the history we have for it it has risen 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4539 per EA |
|---|---|
| All-time high | $0.5968 (Jan 10, 2024) |
| All-time low | $0.3106 (Aug 23, 2023) |
| 52-week high | $0.4539 |
| 52-week low | $0.3826 |
| Median price | $0.4209 |
| Average price | $0.4265 |
| Largest weekly change | +61.6% (Feb 22, 2023) |
| Weeks tracked | 259 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DANTROLENE SODIUM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DANTROLENE SODIUM 25 MG CAP, manufactured by AvPAK, is $0.4539 per EA (NDC 50268021715), effective Jun 24, 2026.
How has the price of DANTROLENE SODIUM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DANTROLENE SODIUM 25 MG CAP has risen 14.8%. It has been tracked across 259 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for DANTROLENE SODIUM 25 MG CAP?
Since Jul 14, 2021, the NADAC for DANTROLENE SODIUM 25 MG CAP has ranged from a low of $0.3106 (Aug 23, 2023) to a high of $0.5968 (Jan 10, 2024), with a median of $0.4209 per EA.
Are there cheaper alternatives to DANTROLENE SODIUM 25 MG CAP?
3 NADAC-published products share the same active ingredient, strength, and dosage form as DANTROLENE SODIUM 25 MG CAP, but none are currently priced below it.
Who manufactures DANTROLENE SODIUM 25 MG CAP?
DANTROLENE SODIUM 25 MG CAP (NDC 50268021715) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification